Graphite Bio Total Revenue

Graphite Bio (GRPH) currently reports a total revenue of $21M as of June 2026. That compares with $-5.2M in the prior-year period — up 510.1% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Graphite Bio's total revenue history and peer comparisons.

Graphite Bio's total revenue increased from $-5.2M to $21M — a 510.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Graphite Bio's total revenue of $21M is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Graphite Bio reported $21M in total revenue as of June 2026. That compares with $-5.2M in the prior-year period — up 510.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $21M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Graphite Bio, and consider following GRPH for alerts when major investors trade the stock.